PETER BARRY
Peter Barry
Published: Friday, May 27, 2016
It is with very great sadness that the ESCRS announces the death of our beloved colleague and friend Dr Peter Barry, who passed away on Thursday, 26 May 2016 after a short illness. The Board, Committees and members of the Society extend their most heartfelt sympathy to his wife Carmel, and family David, Stephen, Simon and Lisa.
Peter was a founding member of the ESCRS, and served as its treasurer, president, director and guiding light. He was a person of great vision who made an immense contribution not only to the success of the ESCRS but to the wider world of ophthalmology. We cannot begin to contemplate his loss. Reposing at St. Vincent’s Mortuary Chapel on Sunday May 29, from 4 pm to 6pm prior to his removal to the Church of Our Lady Queen of Peace, Merrion Road arriving at 6.30 pm. Funeral Mass on Monday morning at 10 am followed by burial at Shanganagh Cemetery. No flowers please. Donation in lieu to Irish Cancer Society.(www.cancer.ie) “We have lost a gentleman”
Latest Articles
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.